Public-registry site landscape for NCT07732400, a Metabolic Dysfunction-associated Steatohepatitis (MASH) study sponsored by Kriya Therapeutics, Inc.. All data below is from public sources; Eichor is not affiliated with the sponsor.
| Trial | NCT07732400 (registry record) |
| Sponsor | Kriya Therapeutics, Inc. |
| Condition(s) | Metabolic Dysfunction-associated Steatohepatitis (MASH) |
| Phase | PHASE1 / PHASE2 |
| Listed sites | 3 |
| Site countries | United States, New Zealand |
Eichor generates a preliminary site-risk snapshot for NCT07732400 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →